Innovative treatments and therapies from cannabis industry
March 14, 2017The expansion of product lines and enhanced product development are fueling rising revenues and overall growth in the swelling cannabis market despite recent ambiguous reports of direction of the federal impact on the legal marijuana market, according to a report by MarketNewsUpdates.com.
In product and increased production developments, NewGen Concepts, Inc., formerly Vapor Group, Inc said Tuesday that because of the tremendous demand for Easy Grinder, one of the largest distributors of CBD oil in the U.S. is negotiating for the distribution of Easy Grinder across the U.S. The agreement represents a major distribution leap for Easy Grinder since the CBD distributor sells to over 7,000 resellers and retail outlets, giving Easy Grinder a huge diverse retail presence. As a result, future production runs of Easy Grinder will significantly increase. The first two production runs of over 40,000 units (March and June) have already sold out, causing the company to accelerate production and delivery by opening its own manufacturing facility in China, says the report.
Retail and wholesale demand for Easy Grinder continues strong and is projected to represent a major impact on 2017 revenues and profits.
Zynerba Pharmaceuticals, Inc. closed up on Monday at $20.77 trading over 450,000 shares by the market close. Zynerba Pharmaceuticals, a clinical-stage specialty pharmaceutical company, dedicated to the development of innovative transdermal synthetic cannabinoid treatments, on Monday said the fourth quarter and full-year 2016 financial results and recent operating progress will be reported on Monday, March 27, 2017.
CV Sciences, Inc. closed up slightly on Monday at $0.37 . CV Sciences, Inc., a preeminent supplier and manufacturer of hemp-derived CBD oil bulk and consumer products, on Monday announced the launch of the first online education platform designed to enhance its brand education and advocacy, through Experticity. Currently over 750 consumer brands, including The North Face, Dyson, and Quiksilver, are working with Experticity to educate and tap into real-life experts (industry professionals, category opinion leaders, online influencers and passionate retail sales associates), to create a new breed of buying experience — one that is informed, genuine and mutually beneficial for retailers and consumers. CV Sciences’ education platform will cover a variety of topics pertaining to hemp, phytocannabinoids, and its industry-dominating consumer products brand, PlusCBD Oil.
MarketNewsUpdates.com further noted that Medical Marijuana, Inc. closed up over 5% on Monday trading over 9.9 Million shares by the market close. Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States , announced last week that its major investment company AXIM Biotechnologies, Inc. has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS), with the company’s CanChew Plus CBD gum.